Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 6204
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 38nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 42nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 43nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 45nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 56nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 58nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 61nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 74nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 79nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 82nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 86nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 91nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 102nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 108nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 109nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 123nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 151nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 151nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 182nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 253nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 295nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 297nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 386nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 451nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 453nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 498nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 553nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 559nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 648nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 732nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 762nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 846nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 926nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 930nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.01E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.02E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.20E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.31E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.33E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.34E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.57E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.58E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.59E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.65E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.74E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.77E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 1.99E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 2.11E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 2.14E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
TargetPeptidyl-prolyl cis-trans isomerase FKBP5(Human)
The Technical University of Darmstadt
US Patent
The Technical University of Darmstadt
US Patent
Affinity DataKi: 2.45E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info











3D Structure (crystal)





































